$VRCA Cashflow Statement | Understand Stock

$VRCA

$3.47 +$0.05 (1.46%) Live

$VRCA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Amortization of premiums on marketable securities
Depreciation expense
Non-cash interest expense
Amortization on operating lease right-of-use asset
Loss on disposal of fixed assets
Amortization of operating lease right-of-use asset
Amortization of finance lease right-of-use asset
Change in obligation for R&D Funding liability
Non-cash R&D expense related to warrant vesting
Impairment of right-of-use asset
Loss on termination of financing lease
Loss on extinguishment of debt
Change in fair value of derivative liability

Changes in operating assets and liabilities:
Prepaid expenses and other assets
Deferred revenue
Accounts payable
Accounts receivable
Collaboration receivable, billed and unbilled
Accrued expenses and other current liabilities
Operating lease liability
Net cash used in operating activities
Cash flows from investing activities
Sales and maturities of marketable securities
Purchases of marketable securities
Purchases of property and equipment
Deposits
Sale of fixed assets
Net cash used in investing activities
Cash flows from financing activities
Proceeds from exercise of stock options
Proceeds from issuance of debt, net of issuance costs
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs
Proceeds from issuance of common stock, pre-funded warrants and Series A and B warrants, net of issuance costs
Proceeds from issuance of common stock, pre-funded warrants and warrants
Issuance costs for common stock, pre-funded warrants and warrants
Cash paid to settle debt
Debt issuance costs
Debt amendment costs
Repayment of finance lease
Net cash provided by financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Supplemental disclosures
Cash paid for interest
Supplemental disclosure of noncash investing and financing activities:
Property and equipment purchases in accounts payable or accrued expenses and other current liabilities at year end
Change in unrealized loss on marketable securities
Fair value of warrants issued with debt
Recognition of R&D funding liability and deferred R&D services
Non-cash accruals for equity issuance costs
Right-of-use asset obtained in exchange for lease obligation
Extinguishment of finance lease liability as a result of lease termination
Extinguishment of operating lease liability as a result of lease termination

Comments